NCT06059924

Brief Summary

The aim of this retrospective cohort-study is to assess the effects of AL and its severity divided according the ISREC-classification on the long-term oncological outcome.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
941

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 1991

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 1991

Completed
29.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2020

Completed
2.7 years until next milestone

First Submitted

Initial submission to the registry

September 15, 2023

Completed
14 days until next milestone

First Posted

Study publicly available on registry

September 29, 2023

Completed
Last Updated

September 29, 2023

Status Verified

September 1, 2023

Enrollment Period

29.9 years

First QC Date

September 15, 2023

Last Update Submit

September 22, 2023

Conditions

Keywords

Rectal cancerLow rectal resectionAnastomotic leakageISREC-classificationCancer-specific survivalPropensity score

Outcome Measures

Primary Outcomes (1)

  • Cancer-specific survival

    30 days postoperative to 5 years postoperative

Secondary Outcomes (3)

  • Overall survival

    30 days postoperative to 5 years postoperative

  • Disease-free survival

    30 days postoperative to 5 years postoperative

  • Recurrence-free survival

    30 days postoperative to 5 years postoperative

Study Arms (2)

leak

Patients with diagnosed anastomotic leakage after low rectal resection for rectal cancer UICC stage I to III

Other: Anastomotic leakage

noleak

Patients without anastomotic leakage after low rectal resection for rectal cancer UICC stage I to III

Interventions

Anastomotic leakage was defined as a defect of the intestinal wall at the anastomotic site leading to a communication between the intra- and extraluminal compartments. It was diagnosed by clinical, laboratory, radiological (ultrasound, endosonography, computed tomography), endoscopic, and/or surgical findings.

leak

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients operated at the Cantonal Hospital of St. Gallen

You may qualify if:

  • Patients receiving elective low anterior resection (LAR) between February 1991 and December 2020 at the Cantonal Hospital of St. Gallen

You may not qualify if:

  • Other diagnosis than rectal cancer
  • Discontinuity resection (no anastomosis)
  • Emergency situation
  • R1-resection
  • Incomplete staging
  • Metastatic cancer
  • day mortality
  • Decline of a retrospective data analysis
  • Secondary malignancy
  • Age under 18 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cantonal Hospital of St. Gallen

Sankt Gallen, 9000, Switzerland

Location

Related Publications (1)

  • Rahbari NN, Weitz J, Hohenberger W, Heald RJ, Moran B, Ulrich A, Holm T, Wong WD, Tiret E, Moriya Y, Laurberg S, den Dulk M, van de Velde C, Buchler MW. Definition and grading of anastomotic leakage following anterior resection of the rectum: a proposal by the International Study Group of Rectal Cancer. Surgery. 2010 Mar;147(3):339-51. doi: 10.1016/j.surg.2009.10.012. Epub 2009 Dec 11.

    PMID: 20004450BACKGROUND

MeSH Terms

Conditions

Rectal NeoplasmsAnastomotic Leak

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesIntestinal DiseasesRectal DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Ignazio Tarantino, PD Dr. med.

    Klinik für Chirurgie, Cantonal Hospital of St. Gallen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Physician

Study Record Dates

First Submitted

September 15, 2023

First Posted

September 29, 2023

Study Start

February 1, 1991

Primary Completion

December 31, 2020

Study Completion

December 31, 2020

Last Updated

September 29, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations